Aptevo and Niowave form partnership for cancer drug development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. MRK

Go back to Aptevo and Niowave form partnership for cancer drug development
(NASDAQ: APVO) Delayed: 4.74 +0.11 (2.38%)
Previous Close $4.63    52 Week High $4.33 
Open $4.84    52 Week Low $1.80 
Day High $4.84    P/E N/A 
Day Low $4.68    EPS $0.00 
Volume 11,949